Form 4 for TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Accepted 2025-12-11 00:00:00 ET · period of report 2025-12-09 · accession 0001193125-25-315938 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-11 | 2025-12-09 | TEVA | Daniell Richard | EVP, European Commercial | M - OptEx | $18.40 | +115.5K | 163.9K | +239% | +$2.12M |
| D | 2025-12-11 | 2025-12-09 | TEVA | Daniell Richard | EVP, European Commercial | S - Sale+OE | $28.68 | -115.5K | 48.4K | -70% | -$3.31M |
| DM | 2025-12-11 | 2025-12-09 | TEVA | Daniell Richard | EVP, European Commercial | M - OptEx | $0.00 | -115.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-12-09 | M | A | 100,457 | $18.61 | 148,841 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. |
| 2 | Common | Ordinary Shares | 2025-12-09 | M | A | 15,011 | $16.99 | 163,852 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. |
| 3 | Common | Ordinary Shares | 2025-12-09 | S | D | 115,468 | $28.68 | 48,384 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.635 to $28.765, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Derivative | Stock Options (right to buy) | 2025-12-09 | M | D | 100,457 | $0.00 | 0 | D | $18.61 · — to 2028-02-09 | 100,457 Ordinary Shares | (F3) Stock options were granted on February 9, 2018, with 33,485 vested on each of February 9, 2020 and February 9, 2021, and 33,487 vested on February 9, 2022. |
| 5 | Derivative | Stock Options (right to buy) | 2025-12-09 | M | D | 15,011 | $0.00 | 0 | D | $16.99 · — to 2027-09-18 | 15,011 Ordinary Shares | (F4) Stock options were granted on September 18, 2017, with 7,505 vested on September 18, 2018, and 7,506 vested on September 18, 2019. |